14,737 Shares in Revvity, Inc. (NYSE:RVTY) Bought by Yousif Capital Management LLC

Yousif Capital Management LLC acquired a new stake in shares of Revvity, Inc. (NYSE:RVTY - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 14,737 shares of the company's stock, valued at approximately $1,611,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. bought a new stake in shares of Revvity in the 3rd quarter worth about $1,579,487,000. Ceredex Value Advisors LLC bought a new position in Revvity in the 4th quarter worth about $108,353,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in shares of Revvity during the fourth quarter worth approximately $33,568,000. Boston Trust Walden Corp purchased a new stake in shares of Revvity in the fourth quarter valued at approximately $25,154,000. Finally, KBC Group NV bought a new position in Revvity in the third quarter worth approximately $25,301,000. 86.65% of the stock is owned by hedge funds and other institutional investors.

Revvity Trading Down 0.5 %

RVTY traded down $0.47 during trading hours on Friday, reaching $100.61. The company's stock had a trading volume of 858,959 shares, compared to its average volume of 848,190. The business's 50-day moving average is $104.56 and its 200-day moving average is $101.28. The company has a debt-to-equity ratio of 0.40, a current ratio of 2.23 and a quick ratio of 1.77. The stock has a market cap of $12.43 billion, a PE ratio of 83.15, a P/E/G ratio of 2.67 and a beta of 1.09. Revvity, Inc. has a fifty-two week low of $79.50 and a fifty-two week high of $132.54.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, April 29th. The company reported $0.98 EPS for the quarter, topping the consensus estimate of $0.94 by $0.04. Revvity had a net margin of 5.49% and a return on equity of 7.37%. The firm had revenue of $649.90 million for the quarter, compared to analyst estimates of $646.83 million. During the same period in the prior year, the business posted $1.01 EPS. The business's revenue for the quarter was down 3.7% compared to the same quarter last year. As a group, equities research analysts predict that Revvity, Inc. will post 4.65 earnings per share for the current fiscal year.

Revvity Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Shareholders of record on Friday, July 19th will be given a $0.07 dividend. This represents a $0.28 annualized dividend and a yield of 0.28%. The ex-dividend date is Friday, July 19th. Revvity's dividend payout ratio is currently 23.14%.

Insiders Place Their Bets

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the firm's stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total value of $2,212,508.76. Following the completion of the transaction, the insider now owns 92,801 shares of the company's stock, valued at approximately $9,677,288.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.60% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on RVTY shares. Stifel Nicolaus upped their price objective on shares of Revvity from $95.00 to $110.00 and gave the stock a "hold" rating in a research note on Friday, February 2nd. TD Cowen upped their target price on Revvity from $123.00 to $130.00 and gave the stock a "buy" rating in a report on Tuesday. Raymond James increased their price target on shares of Revvity from $106.00 to $127.00 and gave the company an "outperform" rating in a research report on Friday, February 2nd. UBS Group lowered shares of Revvity from a "buy" rating to a "neutral" rating and boosted their price objective for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. Finally, Evercore ISI upgraded shares of Revvity from an "in-line" rating to an "outperform" rating and raised their target price for the company from $88.00 to $125.00 in a research note on Thursday, January 4th. Six investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company's stock. According to MarketBeat, Revvity has a consensus rating of "Moderate Buy" and a consensus target price of $118.17.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.